Searched for: subject%3A%22Pharmaceutical%255C+Industry%22
(1 - 8 of 8)
document
Lopes Vieira, Mariana (author)
master thesis 2022
document
Hagenaars, Rosalie (author)
This thesis explores the relatively large contribution of the product category ‘chemicals n.e.c.’ (chemicals not elsewhere classified) to the Dutch healthcare sector’s carbon and material footprint observed in previous studies. For this, an input-output study using SNAC-EXIOBASE data was performed. SNAC-EXIOBASE uses national statistics for the...
master thesis 2022
document
Doornenbal, Eline (author)
The R&D productivity crisis is among the most pressing issues in the drug industry. The increasing costs and stable R&D outputs jeopardise the industry’s economic health, drug innovation, and the accessibility and affordability of medicines. The pharmaceutical R&D productivity problem is expected to be diminished due to...
master thesis 2021
document
Dinmohamed, R.R. (author)
master thesis 2016
document
De Jonge, C.H.M. (author)
master thesis 2014
document
Uhlig, T. (author), Kyprianou, T.D. (author), Martinelli, F.G. (author), Oppici, C.A. (author), Heiligers, D. (author), Hills, D.R.J. (author), Calvo, X.R. (author), Verhaert, P.D.E.M. (author)
This minireview touches upon the challenges and opportunities peptides experience on the track to become an approved pharmaceutical. Peptide attributes originally considered troublesome with respect to drug development may now turn out to be more convenient rather than unfavourable. Besides characteristic high target affinity, biological...
journal article 2014
document
Das, V.L. (author)
The pharmaceutical industry has been spending an increasing amount of money on R&D over the years. However, fewer drugs have been approved by the FDA and the EMA recently. This lack in innovation performance is a problem which needs to be solved in order to continue finding medicines for cureless diseases. Innovation lies at the heart of the...
master thesis 2014
document
Van Vierssen Trip, F.W. (author)
The pharmaceutical industry is in a R&D productivity crisis. Rapidly increasing development costs, decreasing profitability of new medical entities and missing breakthrough innovation are afflicting the future of the pharmaceutical industry. This complex problem requires a systems thinking approach. In this study, we ought to map the general...
master thesis 2013
Searched for: subject%3A%22Pharmaceutical%255C+Industry%22
(1 - 8 of 8)